HSD43 COPD Patients Receiving Fixed or Open-Label Triple Therapy: Initiation and Persistence of Treatment Based on Data From a Real-World Ambulatory Medicalized Database in France
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1386
https://www.valueinhealthjournal.com/article/S1098-3015(22)03591-4/fulltext
Title :
HSD43 COPD Patients Receiving Fixed or Open-Label Triple Therapy: Initiation and Persistence of Treatment Based on Data From a Real-World Ambulatory Medicalized Database in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03591-4&doi=10.1016/j.jval.2022.09.1386
First page :
Section Title :
Open access? :
No
Section Order :
10933